ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Business deals

Sun Pharmaceutical to acquire Pola Pharma in push for Japanese expansion

Deal to help Indian drugmaker launch specialty, generic dermatology products Japan

Sun Pharmaceutical Industries expects the deal to help it launch its specialty and generic dermatology products in the Japanese market.   © Reuters

MUMBAI (NewsRise) -- Sun Pharmaceutical Industries agreed to buy smaller rival Pola Pharma in Japan, as Indian drugmakers seek to create a niche in markets outside the U.S.

India's biggest pharmaceutical company said it plans to buy Pola Pharma, which is into research and development, manufacturing, sale and distribution of branded and generic products primarily in dermatology, for $1 million in equity, barring debt and cash. The deal is likely to be completed by January, it said without disclosing further details about the financial transaction.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more